Fact-checked by Grok 2 weeks ago

GTCR

GTCR LLC is a Chicago-based founded in 1980 that specializes in leveraged buyouts, , and rollup transactions, primarily in the healthcare, and , and sectors. The firm pioneered its "Leaders Strategy," which focuses on identifying and partnering with experienced management leaders to drive value creation in portfolio companies, rather than relying solely on . Employing deep sector expertise developed over more than four decades, GTCR has committed over $30 billion of capital across approximately 290 investments and currently manages about $50 billion in equity. Notable achievements include successful exits generating significant returns, such as the recent acquisition of a stake in Worldpay from Services at an $18.5 billion valuation, contributing to over $5 billion in distributions to investors amid a streak of high-profile realizations. GTCR's investment approach has emphasized healthcare since 1981, alongside and other growth areas, with recent deals including a $1.33 billion investment in firm , valuing it at $4.5 billion, and the acquisition of Innovative Systems in elder care . Headquartered at 300 North LaSalle in , the firm maintains a low public profile typical of but has built a reputation for operational improvements and strategic partnerships that enhance portfolio company performance.

Overview

Founding and Core Principles

GTCR was established in in , , initially as Golder Thoma & Co., by Stanley Golder, Carl Thoma, and Bryan Cressey, marking it as one of the early firms in the United States focused on investments. The firm's origins emphasized with experienced management teams to execute growth strategies, departing from contemporaneous approaches that often prioritized leveraged buyouts with heavy debt loads and limited operational involvement. This foundational orientation positioned GTCR to target middle-market companies where leadership execution could drive sustainable value creation, rather than relying primarily on financial restructuring or asset sales. At its core, GTCR pioneered The Leaders Strategy™, a differentiated investment framework that centers on identifying and partnering with proven executives—termed "Leaders"—to lead companies through transformative growth. This approach integrates four key elements: sourcing exceptional management talent, leveraging deep sector expertise in areas like healthcare, , and , executing operational enhancements via buy-and-build tactics, and fostering disciplined capital allocation to scale businesses organically and through acquisitions. Unlike strategies dependent on alone, The Leaders Strategy prioritizes causal drivers of performance, such as strategic pivots under capable leadership, to generate returns through revenue expansion and efficiency gains, evidenced by the firm's track record of over 80 company exits since 2000. From its inception with modest buyouts, GTCR has evolved into a firm managing more than $45 billion in equity capital as of 2025, having committed over $30 billion across more than 280 companies. This scaling reflects the enduring viability of its principles, with recent funds like the $11.5 billion underscoring a continued commitment to leadership-partnered investments amid expanding market opportunities.

Scale and Operations

GTCR manages more than $45 billion in equity capital, supporting its focus on growth-oriented buyouts across targeted sectors. The firm, headquartered at 300 North LaSalle Street in , , employs over 225 professionals across offices in , , and West Palm Beach, drawing on more than 40 years of accumulated sector expertise to identify and execute investments. Since its founding, GTCR has deployed over $30 billion in capital across more than 280 companies, emphasizing efficient deployment through leveraged buyouts, recapitalizations, and strategic add-ons that enhance portfolio company value. In 2025, the firm achieved record acquisition activity with eight deals, including acquisitions of Innovative Systems, FMG Suite, and Dentalcorp, underscoring operational resilience amid market volatility via targeted partnerships and disciplined capital allocation. This scale enables GTCR to maintain a robust pipeline, with active funds like the $11.5 billion Fund XIV and $3.6 billion Strategic Growth Fund II facilitating ongoing deployment.

Investment Strategy

The Leaders Strategy Framework

GTCR's Leaders Strategy represents a proprietary framework that prioritizes the identification and with experienced executives to drive the acquisition, transformation, and growth of middle-market companies. Developed since the firm's founding in , the approach integrates GTCR's capital with executives' operational expertise, focusing on sectors such as , telecommunications, healthcare, and business services. Central to the framework is the tenet that "identifying the right leader is the critical difference in building market-leading companies," emphasizing of proven operators with domain-specific track records to lead value creation efforts. The strategy operates through a structured process: GTCR first sources and vets leaders—often full-time CEOs or operators with visionary plans—before targeting acquisition opportunities aligned with their expertise. Incentives are aligned via participation and in , fostering sustainable growth through organic expansion, operational improvements, and strategic add-on acquisitions rather than reliance on heavy or short-term financial maneuvers. This contrasts with traditional models prevalent in private equity, which frequently prioritize debt-financed extractions and rapid exits; GTCR's model instead empowers leaders to execute long-term transformations, applying firm-wide sector knowledge to enhance efficiencies and scalability. Evidence of the framework's efficacy lies in its consistent application across over 200 investments since , where management partnerships have facilitated repeated cycles of company building and exits, demonstrating against industry critiques of short-termism. By committing resources to networks and bearing the costs of such relationships, GTCR positions itself to capitalize on leaders' ability to navigate complex markets, yielding compounded returns through repeated platform developments and bolt-on integrations.

Sector Specializations

GTCR concentrates its investments in four primary sectors characterized by high growth potential and opportunities for : healthcare, business and , and , and , media, and (TMT). This sector-specific approach leverages dedicated teams of investment professionals who possess deep , enabling targeted evaluations of market dynamics, regulatory environments, and technological disruptions within each area. In healthcare, GTCR targets subsectors including life sciences, pharmaceuticals, medical devices, and healthcare services, focusing on companies positioned for innovation amid evolving reimbursement models and demographic-driven demand. The firm pursues strategies such as platform build-outs and add-on acquisitions in fragmented markets to consolidate operations, enhance efficiencies, and accelerate product development pipelines, thereby fostering scalable platforms that improve service delivery and competitive positioning. For business and consumer services, investments emphasize growth-oriented firms in marketing technology, professional services, and consumer-facing operations, where GTCR applies expertise to integrate digital tools and optimize service models for expanded market reach. In and technology, the focus lies on innovations, payment processing, and solutions, capitalizing on regulatory shifts and digital adoption to drive revenue diversification and risk-adjusted growth. Similarly, in TMT, GTCR invests across software, information services, and infrastructure, prioritizing assets that benefit from data analytics, cloud migration, and connectivity expansions to achieve network effects and operational leverage. This specialization facilitates roll-up transactions in industries with high fragmentation, where GTCR combines complementary assets to realize cost synergies, standardize processes, and strengthen bargaining power with suppliers and customers—outcomes that empirical analyses of attribute to enhanced industry efficiency rather than mere market dominance. By aligning capital with sector-tailored leadership and operational enhancements, GTCR's model promotes sustained innovation and competitive resilience, as evidenced by its consistent deployment of resources into transformative opportunities within these domains.

Historical Development

Inception and Early Investments (1980-1999)

GTCR traces its origins to 1980, when Stanley Golder and Carl Thoma established Golder Thoma & Co. in as a focused on buyouts and venture investments. Golder, who had developed First Chicago's private equity activities during the 1970s, emphasized partnerships with experienced management teams to drive value through operational enhancements and consolidation strategies, an approach that foreshadowed later industry practices. The firm's initial efforts centered on mid-market deals , capitalizing on regional opportunities in sectors with potential for growth and resilience amid the era's economic uncertainties. During the early 1980s, GTCR pursued a broad spectrum of investments, including turnarounds, startups, and leveraged buyouts, while navigating the and subsequent . This period tested the firm's of prioritizing companies with strong underlying fundamentals and executable operational improvements, allowing it to build a foundational track record without over-reliance on highly cyclical industries. By , the firm was actively raising capital from limited partners, signaling early recognition of its approach's potential to generate returns through involvement rather than passive holdings. Structural evolution bolstered GTCR's capabilities: Bryan Cressey joined in 1984, prompting a rename to Golder Thoma Cressey, followed by David Rauner's addition in 1986, which finalized the GTCR moniker. Throughout the , the firm continued mid-market focus, refining its buy-and-build model—pioneered in its earliest deals—to consolidate fragmented industries, thereby demonstrating the viability of executive-led transformations and attracting broader institutional interest. These formative investments and exits, though modest in scale compared to later funds, established credibility by delivering consistent performance across economic cycles, including the early downturn.

Growth Phase and Fund Evolution (2000-2010)

In the early 2000s, GTCR scaled its fund sizes amid the post-dot-com recovery, closing GTCR Fund VII with $2 billion in commitments around 2000, enabling larger transactions such as an $800 million acquisition from in 2001 that deployed approximately $200 million in equity. This marked a shift toward multi-billion-dollar vehicles, with Fund VIII closing in 2003 at $1.8 billion and Fund IX in 2006 at $2.75 billion, surpassing the firm's prior targets and attracting commitments primarily from pension funds and endowments. Under chairman , who joined in 1981 and led strategic expansion, GTCR broadened from Midwest-focused deals to national-scale investments across sectors like , , and , exemplified by the 2000 acquisition of Alliant Insurance Services. The firm also deepened its healthcare commitments during this decade, investing in services and payors amid rising demand from demographic shifts, including platforms like APS Healthcare, laying groundwork for over $20 billion deployed in the sector since 2000 across roughly 100 companies. GTCR navigated the with relative stability, deploying over $600 million from Fund IX into opportunities like specialty insurance by 2009 while many competitors halted activity due to credit tightening. The firm's emphasis on partnering with strong leaders facilitated value creation through operational improvements rather than aggressive , allowing purchases at discounted valuations and positioning Fund IX for a 0.1% net return by end-2010—above its vintage peers despite market turmoil.

Modern Expansion and Recent Milestones (2011-Present)

Following a period of steady fund evolution in the prior decade, GTCR significantly expanded its scale from , exemplified by the formation and rapid growth of portfolio companies like AssuredPartners, which achieved its 500th acquisition milestone by late 2024, underscoring the firm's focus on buy-and-build strategies. The firm raised its tenth fund with $3.25 billion in commitments by early , followed by larger vehicles, including a record $11.5 billion flagship fund in May 2023, which contributed to surpassing $35 billion by that year. In January 2022, GTCR closed its inaugural $2 billion Strategic Growth Fund to target equity investments of $50 million to $200 million per deal, broadening opportunities in mid-market growth segments. GTCR pursued aggressive platform acquisitions amid evolving market conditions, including the October 2023 purchase of ADT's commercial fire and security business for approximately $1.6 billion, partnering with former executives to bolster its security sector holdings. To counter regulatory scrutiny and economic volatility, the firm increasingly relied on add-on deals for operational synergies, completing hundreds across portfolios; for instance, its Technology, Media, and Telecommunications group executed over 185 such transactions since 2000, many post-2011, to drive revenue growth and efficiency in existing platforms. The year represented a peak in activity, with GTCR completing eight acquisitions—the highest annual tally on record—as markets stabilized post-volatility. Key deals included the August 27 acquisition of Innovative Systems, a provider of billing and software for rural providers, to expand capabilities; the September 10 close on FMG Suite, a platform for financial advisors; and the October 21 investment in insurance broker JMG Group alongside Synova LLP, aimed at fueling further M&A in that market. A standout milestone was the July sale of payment processor Worldpay for $24 billion, the largest exit of the year, highlighting GTCR's ability to generate substantial returns despite broader industry headwinds. By mid-, assets under management reached $45 billion, reflecting sustained capital inflows and successful deployments.

Notable Deals and Portfolio

Healthcare and Life Sciences Investments

GTCR's healthcare and life sciences investments encompass a broad range of subsectors, including medical devices, pharmaceuticals, healthcare services, and life science tools, with the firm completing approximately 65 platform investments in healthcare over its 44-year history and more than 25 new platforms since 2010. As of early , the portfolio featured 17 operating companies and two management start-ups, which collectively executed over 75 add-on acquisitions to enhance scale and capabilities. These efforts have targeted growth-oriented firms, leveraging operational improvements and executive partnerships to drive expansion in fragmented markets. A notable example in medical technology involved GTCR's proposed 2025 acquisition of Surmodics, Inc., a developer of coatings for vascular medical devices, for $43 per share in cash, valuing the equity at approximately $627 million. The U.S. challenged the deal in March 2025, alleging it would result in GTCR controlling over 50% of the U.S. market for hydrophilic coatings used on guidewires and other interventional devices, potentially reducing competition and innovation in a concentrated segment. Surmodics contested the 's assessment, asserting the merger would promote efficiencies and had received approval from antitrust authorities in multiple jurisdictions, and vowed to defend the transaction in court. The challenge, joined by state attorneys general from and in April 2025, underscored regulatory scrutiny of private equity-driven consolidation in specialized medtech areas, where market shares are already limited to a few players. Earlier healthcare forays included investments in providers, such as the GTCR funds' backing of Trans Health Management, Inc. (THMI), which operated through subsidiaries in the early . This stake, aimed at building a national network, encountered significant challenges, culminating in THMI's proceedings where allegations arose of asset transfers to shell entities to offload liabilities from underperforming facilities. GTCR ultimately incurred losses exceeding $60 million on the investment, characterized by a former partner as a "financial disaster" amid operational and regulatory pressures in the sector. Such experiences highlight risks in healthcare services investments, including vulnerability to litigation over care quality and financial structuring. In medtech and life sciences, GTCR has pursued scaling strategies through add-on acquisitions and leadership alignments, as seen in past holdings like Actient Pharmaceuticals, which focused on therapeutics, and ongoing emphases on device . These approaches have facilitated market efficiencies by fragmented supply chains and enhancing R&D capabilities, though independent linking such investments directly to superior patient outcomes remains limited, with firm-reported metrics emphasizing revenue growth and exit multiples instead. Critics of in healthcare, including in device and services , argue that operational cost controls may prioritize profitability over care quality, yet GTCR's track record includes exits that returned capital to investors while expanding service delivery in underserved areas. Overall, the firm's healthcare activities reflect a tension between fostering through capital deployment and navigating antitrust and operational critiques in highly regulated domains.

Business Services and Technology Acquisitions

GTCR targets acquisitions in business services and within fragmented markets, such as regional and financial advisory tools, where inefficient incumbents create opportunities for digital consolidation and operational upgrades. These investments leverage the firm's Leaders to partner with experienced teams, focusing on scalable software platforms that drive revenue expansion through enhanced automation and features. A key 2025 example is the September 10 acquisition of FMG Suite from Aurora Capital Partners, a provider serving over 10,000 financial advisors and agents with compliant , SEO tools, and client communication platforms. GTCR plans to accelerate FMG's growth by expanding its product offerings and integrating advanced AI capabilities, positioning it to capture share from legacy manual processes in the advisory sector. On August 27, 2025, GTCR acquired Innovative Systems from Alpine Investors, a software firm delivering solutions, billing, customer care, and digital activation for regional providers. This deal addresses the fragmented rural landscape, enabling operators to modernize against national competitors by streamlining back-office functions and improving service deployment, which supports subscriber growth in underserved markets. Such transactions demonstrate GTCR's emphasis on transformative s that prioritize platform scaling and over short-term efficiencies, building on a track record of vertical software successes that enhance market competitiveness and operational expansion.

Other Sector Highlights

GTCR has extended its Leaders Strategy to through targeted s that leverage operational partnerships with experienced management teams. In October 2025, GTCR completed a strategic in JMG Group, a leading insurance broker placing over £350 million in annual premiums, alongside Synova LLP, to fuel acquisitions, talent development, and platform enhancements under CEO . This move exemplifies diversification into brokerage, an ancillary financial subsector, by integrating add-on opportunities to scale broker capabilities amid market consolidation. In the security and safety domain, GTCR acquired ADT's commercial and business in October 2023 for $1.6 billion, rebranding it as Everon to focus on enterprise solutions including , , and services. Post-acquisition, Everon has pursued innovations such as integrated technology platforms for and expanded service offerings, partnering with former executives to drive efficiency in fragmented markets. Similarly, GTCR's September 2025 agreement to acquire , a residential provider, marks its fifth entry in the alarm sector, emphasizing bolt-on synergies for broader risk mitigation across commercial and consumer segments. These investments have yielded efficient capital returns via exits that apply the Leaders Strategy universally. For instance, GTCR's involvement in Worldpay, a payments , culminated in a May 2025 sale to for $24.3 billion, generating substantial distributions to limited partners while demonstrating adaptability in transitions. Such outcomes underscore GTCR's approach to sector-agnostic growth, where ancillary holdings buffer core exposures through resilient, management-led value creation.

Leadership and Governance

Founding and Key Executives

GTCR was founded in 1980 in as Golder Thoma & Co. by Stanley Golder, Carl Thoma, and Bryan Cressey, who drew on early principles from their prior roles at First Chicago Venture Capital. The firm initially focused on growth-oriented investments, evolving through name changes to GTCR Golder Rauner and eventually GTCR LLC, while retaining a commitment to partnering with experienced management teams in targeted sectors. Current leadership centers on co-CEOs Constantine "Dean" Mihas and Collin E. Roche, both managing directors whose promotions reflect internal merit-based advancement tied to investment performance and operational contributions. Mihas joined in 2001 following his role as CEO and co-founder of Delray Farms, bringing expertise in business scaling that aligns with GTCR's emphasis on operational value creation. Roche, who entered the firm in 1996 after serving as an associate at EVEREN Securities, leads efforts in and , leveraging over 25 years of tenure to oversee key portfolio decisions. This continuity from the founders' legacy emphasizes "The Leaders Strategy," which prioritizes sector specialists and accountable executives to drive outsized returns. Deep benches of sector experts under Mihas and Roche have sustained GTCR's outperformance, with recent merit-based promotions—such as Kirk Smith and Geoffrey Tresley to managing director in October 2025—reinforcing accountability amid expanding and initiatives. Their experienced decision-making contributed to heightened 2025 activity, including the $4.8 billion acquisition of generic drug maker and liquidity events like the Worldpay exit yielding nearly 2x returns for investors in under two years.

Influence of Notable Figures

Bruce Rauner, who joined GTCR in 1981 shortly after its founding, played a pivotal role in the firm's expansion during its formative decades, focusing on investments in outsourced business services and contributing to the rebranding as Golder, Thoma, Cressey, Rauner (GTCR) in 1984. Under his leadership as partner and later chairman until his 2012 retirement, GTCR grew its assets under management to approximately $11 billion by 2014, executing investments totaling over $10 billion across more than 200 companies and achieving multiple successful exits through strategic buyouts and growth initiatives. His emphasis on partnering with experienced management teams laid foundational elements of GTCR's enduring "Leaders Strategy," which prioritizes aligning with sector experts to drive operational improvements and value creation in portfolio holdings. Rauner's subsequent entry into politics, culminating in his election as in , introduced potential networks for regulatory navigation, yet GTCR's post-retirement trajectory—managing over $40 billion in equity assets by the and sustaining high internal rates of return through independent deal execution—demonstrates that the firm's achievements stemmed primarily from repeatable investment discipline rather than political leverage. This separation underscores a business legacy rooted in talent cultivation and sector-focused acumen, with and former principals often transitioning to executive roles that perpetuate GTCR's model of executive-led transformations in portfolio companies. Beyond Rauner, GTCR's approach has fostered broader talent development, as evidenced by the firm's of elevating internal professionals and recruiting leaders who subsequently helm acquired entities, enabling successes such as the scaling of diversified holdings in healthcare and without reliance on external favoritism. Such outcomes highlight institutional mechanisms for merit-based advancement over , with past leaders' influences manifesting in enduring frameworks like the Leaders Strategy that have supported over 280 investments and billions in realized returns.

Performance Metrics

Investor Returns and Exits

GTCR achieved a projected return exceeding $5 billion to limited partners in 2025 through a series of timely exits, contrasting with broader liquidity constraints amid elevated rates and subdued valuations. This performance included the firm's sale of payments processor Worldpay in a $24.25 billion three-way transaction in April 2025, which delivered approximately a 2x multiple on invested capital after just two years of ownership. The deal marked the largest private equity exit in for the first half of 2025, underscoring GTCR's ability to capitalize on mid-market opportunities while peers faced prolonged hold periods. Historically, GTCR's funds have posted net internal rates of return surpassing many industry benchmarks, with the firm's 14th flagship fund (closed at $11.5 billion in 2023) building on prior vintages that averaged 28.1% net IRR across four funds. Specific vintages include Fund XII (2017) at 22.88% net IRR and Fund XIII (2020) at 17.70% net IRR as of mid-2024, both exceeding the top-quartile benchmarks for comparable funds which typically range from 15-20%. These outcomes, attributed in part to the firm's Leaders of partnering with experienced management, have enabled consistent distributions even as the median hold period extended beyond four years industry-wide. Notable prior dispositions further highlight GTCR's exit proficiency, such as the of Sterigenics, which contributed to fund returns of 13.77% as reported by public s, outperforming stagnant portfolios at comparable firms amid market volatility. Overall, GTCR's track record reflects a minimum net IRR floor of 14% since 2000, with a 1.25x valuation hurdle ensuring aligned outcomes.

Economic and Market Impact

GTCR's , centered on partnering with experienced teams to execute transformative , has driven operational efficiencies and expanded presence across companies in high-impact sectors such as healthcare, , and . By emphasizing organic initiatives, technological upgrades, and strategic add-on acquisitions, GTCR enables underperforming or stagnant firms to adopt disciplined cost and revenue-enhancing practices, thereby imposing discipline that boosts overall sector productivity. For instance, in the and domain, GTCR-supported companies have pursued efficiency programs alongside distribution expansions, resulting in scalable operations that better serve competitive markets. This approach counters perceptions of private equity as primarily extractive by fostering sustainable value creation, as demonstrated by GTCR's facilitation of over 75 add-on acquisitions in its healthcare portfolio alone, which generate synergies, , and broader economic contributions through consolidated delivery and R&D advancements. In technology, media, and investments, GTCR has backed nearly 30 companies since , leveraging sector innovations to accelerate product development and , enhancing U.S. competitiveness in digital infrastructure. Such transformations align with broader trends where backed firms exhibit employment growth above private sector averages, with GTCR's model contributing to this by scaling businesses that employ workers in growth-oriented roles. Notable exits underscore GTCR's role in , including the 2025 sale of Worldpay for $24 billion after GTCR's commitment of up to $1.25 billion in , which supported strategic enhancements and positioned the payments processor for heightened transaction volumes integral to GDP contributions. These outcomes reflect causal mechanisms where interventions—such as GTCR's Portfolio Resources Group aiding operational support—yield measurable productivity gains, reinvesting capital into innovative ecosystems rather than mere . Empirical patterns from GTCR's $30 billion-plus investments in over 290 companies indicate a net positive on market dynamics, promoting resource allocation toward high-potential enterprises.

Controversies

Past Legal Disputes

In the early 2000s, GTCR acquired and expanded Trans Healthcare Inc. (THI), a operator of nursing homes including facilities in , amid growing litigation over resident care. Multiple estates of deceased residents filed wrongful death suits in Florida state courts, alleging neglect due to understaffing, inadequate equipment, and at THI-operated homes, resulting in judgments exceeding $2 billion by 2006. Facing financial distress with over 150 lawsuits, GTCR orchestrated a 2006 asset sale of THI's operations to Fundamental Long Term Care Holdings LLC, contributing $20 million in new capital while transferring liabilities to a shell entity, THI, which lacked assets for judgment collection. Plaintiffs, including estates from six Florida cases, pursued fraudulent conveyance claims in U.S. Bankruptcy Court in Tampa, arguing the transaction was designed to evade liabilities rather than rescue the business. GTCR maintained the deal addressed operational insolvency without intent to defraud, as THI was insured against such claims and the sale preserved value. The 2014 trial featured testimony from GTCR executives, including Edgar Jannotta Jr., who denied motives to hinder and highlighted efforts to stabilize the chain amid regulatory and pressures. The court ruled in GTCR's favor, finding no fraudulent transfer, as the transaction provided reasonably equivalent value and was not proven to target avoidance, absolving GTCR of despite the underlying operational failures in resident care. Subsequent settlements with some estates focused on available proceeds, underscoring deficiencies in under prior ownership rather than deliberate evasion by GTCR. This episode prompted GTCR to refine and compliance protocols in healthcare investments to mitigate litigation risks from portfolio company operations.

Antitrust and Regulatory Challenges

In March 2025, the U.S. Federal Trade Commission (FTC) filed a lawsuit to block GTCR's proposed $627 million acquisition of Surmodics, Inc., alleging that the deal would combine two leading providers of hydrophilic coatings for medical guidewires, resulting in the merged entity controlling over 50% of the U.S. market for such coatings. The FTC's complaint emphasized traditional merger concerns, including reduced competition, higher prices, and diminished innovation in the narrowly defined hydrophilic coatings segment, without invoking private equity-specific theories like serial acquisitions or "roll-ups" that had characterized some Biden-era scrutiny. This marked a departure from prior regulatory rhetoric targeting private equity consolidation strategies, reflecting a return to conventional antitrust analysis under the incoming Trump administration's FTC leadership. GTCR contested the FTC's market definition and concentration metrics, arguing through economic analysis that the transaction would not substantially lessen , as alternative suppliers and evolving technologies mitigate dominance risks. The firm highlighted pro-competitive efficiencies, such as enhanced R&D capabilities and scale benefits for customers in the sector, which it claimed outweigh static market share figures. State attorneys general from and joined the FTC's challenge in April 2025, underscoring coordinated enforcement but adhering to standard Hart-Scott-Rodino review processes rather than novel PE-focused interventions. As of October 2025, the administrative proceeding remains unresolved following a two-week evidentiary hearing in September, with a delayed decision anticipated in early 2026; this case illustrates legitimate antitrust vigilance against high-concentration mergers while critiquing potential regulatory overreach in presuming harm from post-merger shares without robust dynamic market evidence. The FTC's approach signals an evolution toward evidence-based, sector-agnostic reviews, avoiding the broader ideological critiques of models seen in earlier Biden administration guidance.

Critiques of Private Equity Model

Critics of the model, including reports from groups, contend that leveraged buyouts financed with high debt levels often result in aggressive cost-cutting, facility closures, and net job losses at portfolio companies, exacerbating . Such claims highlight instances where gross job destruction exceeds baseline employment by around 10% in targeted divisions, attributing this to debt-servicing pressures that prioritize short-term financial engineering over long-term operational health. Empirical analyses, however, reveal a more nuanced picture of , where interventions accelerate both job reallocation and subsequent . A of U.S. buyouts from 1990 to 2006 found that while targets experience initial employment declines of about 1.9% relative to controls in the two years post-buyout, this is offset by faster job creation elsewhere within the firm and positive spillovers to non-target competitors, leading to industry-wide gains. Similarly, -backed firms in the U.S. have been associated with supporting nearly 12 million as of recent estimates, contributing 6.5% to GDP through enhanced operational efficiencies and market discipline. For GTCR, portfolio exits in 2025, including high-value sales generating over $5 billion in returns to investors, demonstrate sustained company valuations and trajectories post-investment, underscoring value creation via management partnerships rather than erosion. Leverage, a core element of the model, carries acknowledged risks, with private equity-owned firms facing roughly 10 times the likelihood of non-PE peers due to amplified financial during downturns. Yet, evidence from data indicates that such discipline incentivizes operational improvements, with targets showing higher and EBITDA growth compared to peers, as managers align incentives toward free-market efficiencies like cost optimization and strategic expansions. GTCR's , including a 2x on its Worldpay within two years culminating in a $24.25 billion exit in April 2025, exemplifies how targeted supports scalable growth without systemic quality degradation, as evidenced by enduring portfolio company performance. Overall, while short-term disruptions occur, causal links from PE involvement favor net economic expansion through rigorous and exit-driven .

References

  1. [1]
    GTCR Chicago Private Equity Firm
    GTCR LLC is a leading private equity firm, based in Chicago, with over 40 years of deep sector expertise.Our TeamInvestmentsHealthcareRecent NewsContact
  2. [2]
    GTCR investment portfolio - PitchBook
    Founded in 1980, GTCR is a private equity firm based in Chicago, Illinois. The firm seeks to invest in financial services & technology, healthcare, media, ...Missing: history | Show results with:history
  3. [3]
    GTCR LLC - LinkedIn
    Aug 27, 2021 · Founded in 1980, GTCR is a leading private equity firm that pioneered The Leaders Strategy™ – finding and partnering with management leaders ...
  4. [4]
    Why GTCR LLC: Interviews, Careers, & Portfolio
    GTCR LLC is one of the leading private equity firms which introduced The Leaders Strategy™. This approach involves teaming up with specialized management ...<|separator|>
  5. [5]
    GTCR Acquires Innovative Systems
    Aug 27, 2025 · Since its inception, GTCR has invested more than $30 billion in over 290 companies, and the firm currently manages approximately $50 billion in ...Missing: achievements | Show results with:achievements<|control11|><|separator|>
  6. [6]
    GTCR - Wikipedia
    GTCR LLC is an American private equity firm focused on leveraged buyout, leveraged recapitalization, growth capital and rollup transactions.
  7. [7]
    GTCR Set to Return Over $5bn to Investors Amid Successful Exit ...
    GTCR acquired its stake from Fidelity National Information Services in July 2024 at an $18.5 billion valuation, backing former chief executive Charles Drucker.
  8. [8]
    Medical and Healthcare Focused Private Equity Firm - GTCR
    Since 1981, private equity investment in healthcare has been a consistent cornerstone of GTCR's strategy. The firm's long history of private equity in the ...
  9. [9]
    GTCR makes $1.33 billion investment in Tricentis
    Nov 26, 2024 · GTCR, a leading private equity firm, has signed a definitive agreement to invest $1.33 billion in the company, valuing the enterprise at $4.5 billion.Missing: achievements | Show results with:achievements
  10. [10]
    GTCR - InvestmentNews
    GTCR is a private equity firm that commits $25 billion in capital across more than 280 companies and currently manages $40 billion in equity assets.
  11. [11]
    The Leaders Strategy - Partnering and Investing with Leaders - GTCR
    As a leading private equity firm, GTCR pioneered The Leaders Strategy™, differentiated approach has stood at the core of our investment strategy.Missing: principles | Show results with:principles
  12. [12]
    [PDF] gtcr-tmt-2025-leadership-newsletter.pdf
    Apr 2, 2025 · We are currently investing out of two vehicles,. GTCR Fund XIV, an $11.5 billion private equity fund raised in 2023, and Strategic Growth Fund, ...
  13. [13]
    GTCR Announces $3.6 Billion Strategic Growth Fund II
    Feb 20, 2025 · Since its inception, GTCR has invested more than $30 billion in over 280 companies, and the firm currently manages more than $45 billion in ...
  14. [14]
    List of 69 Acquisitions by GTCR (Oct 2025) - Tracxn
    Oct 1, 2025 · GTCR has completed 69 acquisitions. Peak activity occurred in 2025 with 8 acquisitions, 2021 with 6, and 2014 with 5.
  15. [15]
    GTCR Notches Busiest Year of Buyouts - Bloomberg.com
    Sep 15, 2025 · All told, the deals mean the firm has already bought more companies in 2025 than in any calendar year, according to the Bloomberg-compiled data ...
  16. [16]
    [PDF] Playing follow the leader at GTCR
    Jan 8, 2016 · "The essence of the Leaders Strategy is combining our capital with a CEO's managerial expertise to provide them with an opportunity to acquire ...
  17. [17]
    [PDF] GTCR's The Leaders Strategy paves the way for successful ...
    Jun 17, 2022 · GTCR pioneered The Leaders. Strategy, which involves partnering with management leaders in core domains to identify, acquire and build market ...Missing: principles | Show results with:principles
  18. [18]
    Deep Sector Expertise | Portfolio Company Investments - GTCR
    The GTCR portfolio includes private equity investments with deep sector expertise with exceptional management partners and top industry leaders.Healthcare Private Equity Firm · Financial Services & TechnologyMissing: achievements | Show results with:achievements
  19. [19]
    Technology, Media and Telecommunications Spring 2025 - GTCR
    The firm currently manages over $45 billion in equity capital. We are currently investing out of two vehicles, GTCR Fund XIV, an $11.5 billion private equity ...
  20. [20]
    Capital AUM | GTCR Overview - Private Equity
    The company was founded in 1980 and has since established itself as an industry leader with a strong track record of success. GTCR focuses on investing in ...
  21. [21]
    Healthcare Winter 2024 - GTCR
    Healthcare has been a long-standing area of focus for GTCR, with investments across life sciences, pharmaceuticals, medical devices, healthcare services and ...
  22. [22]
    Financial Services & Technology Private Equity Investment - GTCR
    GTCR has a long history of private equity investment in financial services and financial technology companies.Missing: specializations | Show results with:specializations
  23. [23]
    Technology, Media & Telecommunications (TMT) Private Equity
    GTCR has a strong history of private equity investment in technology, media and telecom companies within the TMT sector.Missing: specializations | Show results with:specializations
  24. [24]
    GTCR's Exit Mastery: Why Mid-Market PE is the New Frontier for ...
    May 22, 2025 · GTCR's recent performance is no accident. Its success hinges on three pillars: sector specialization, operational excellence, and strategic liquidity timing.
  25. [25]
    GTCR: Chicago's Private Equity Powerhouse Transforming ...
    Jul 31, 2024 · The Leaders Strategy™ drives success in Financial Services, Healthcare, Technology, and Business Services. Recent acquisitions include Surmodics ...
  26. [26]
    GP Profile: GTCR Golder Rauner Tees Up The Deals - Buyouts
    Aug 17, 2009 · History: Founded as Golder Thoma & Co. by Carl Thoma and the late Stanley Golder in 1980. Became Golder Thoma & Cressey in 1984 with the ...
  27. [27]
    The Chicago private equity firm behind a mega-deal - Financial Times
    Jul 6, 2023 · Its roots trace to 1980, when early private equity investors Stanley Golder and Carl Thoma left First Chicago, a loose predecessor to the modern ...<|separator|>
  28. [28]
    GTCR Still Looking To Consolidate - - Buyouts
    Jan 19, 2004 · In the early 1980s, the firm invested in all kinds of deals, from turnarounds and startups to leveraged buyouts. In 1983, while raising their ...
  29. [29]
    Alternative Assets and the "Average" Accredited Investor Installment ...
    Aug 27, 2019 · ... Golder Thoma & Co. Established in 1980 by Stanley Golder and Carl Thoma, Golder Thoma & Co. originated the “consolidation” or “buy and build ...Missing: Robert | Show results with:Robert
  30. [30]
    GTCR Inks $800 Million Buy from Verizon -
    Dec 17, 2001 · GTCR committed around $200 million in equity from its $2 billion Fund VII, which closed two years ago and is about half invested. Lehman ...<|separator|>
  31. [31]
    GTCR Fund VIII Tops $1.8B - - Buyouts
    Nov 17, 2003 · GTCR Golder Rauner, a 20-plus year-old buyout shop with more than $6 billion under management, has closed the window on its eighth fund, ...
  32. [32]
    GTCR Golder Rauner closed its GTCR Fund IX private equity fund at...
    GTCR Golder Rauner closed its GTCR Fund IX private equity fund at $2.75 billion, said Sean Mogle, spokesman.
  33. [33]
    GTCR Closes Its Ninth PE Fund - The New York Times
    Oct 13, 2006 · GTCR Golder Rauner has closed on $2.7 billion for its ninth private equity fund, beating its initial target of $2.25 billion, ...
  34. [34]
    Bruce Rauner - ExcelinEd
    Prior to his public service, Bruce was Chairman of private equity and venture capital firm GTCR, where he and his partners helped form and finance the growth of ...
  35. [35]
    GTCR Acquires Alliant Insurance Services | Mergr M&A Deal Summary
    On March 1, 2000, private equity firm GTCR acquired insurance company Alliant Insurance Services. Acquisition Highlights. This is GTCR's 2nd transaction in ...
  36. [36]
    Past Investments - GTCR
    APS Healthcare ... ATI Physical Therapy, Inc ... Actient Pharmaceuticals ... Aligned Asset Managers ... Alliant Resources Group ... American Medical Laboratories ...Missing: achievements | Show results with:achievements
  37. [37]
    Healthcare Winter 2021 - GTCR
    Since 2000, GTCR has invested over $20 billion in approximately 100 portfolio companies, including more than 70 companies that have been sold for an aggregate ...
  38. [38]
    GTCR invests $200m in specialty insurance company
    Jun 25, 2009 · GTCR has been busy in the market downturn, investing more than $600 million from its $2.75 billion ninth fund, which closed in 2006. In ...
  39. [39]
    On a roll | Crain's Chicago Business
    Jun 18, 2011 · With well-timed deals and $3.25 billion of fresh capital to play with, GTCR is the city's hottest private-equity firm.
  40. [40]
    Financial Services & Technology Leadership Fall 2024 - GTCR
    Since 2000, GTCR has invested over $25 billion in approximately 125 portfolio companies, including more than 80 companies that have been sold for an aggregate ...
  41. [41]
    GTCR Buyout Fund Raises $3.25B | Institutional Investor
    Private equity firm, GTCR, has closed its tenth buyout fund with more than $3.25 billion of equity capital commitments. February 23, 2011.
  42. [42]
    Private equity firm GTCR amasses $11.5 bln in record fundraise
    May 23, 2023 · Chicago-based GTCR was founded in 1980 and has more than $35 billion in assets under management across business services, media, telecoms, ...
  43. [43]
    GTCR Closes $2 Billion Strategic Growth Fund
    Jan 26, 2022 · GTCR, a leading private equity firm founded in 1980, today announced the recent closing of its first Strategic Growth Fund with $2.0 billion of limited partner ...Missing: dollar | Show results with:dollar
  44. [44]
    Security firm ADT's commercial unit to be taken private by GTCR for ...
    Aug 8, 2023 · ADT (ADT.N) said on Tuesday it will sell its commercial security, fire and life safety unit to private equity firm GTCR for $1.6 billion.
  45. [45]
    GTCR Completes Acquisition of FMG, the Leading Marketing ...
    September 10, 2025. GTCR, a leading private equity firm, announced today that it has closed the previously announced acquisition of FMG Suite ...
  46. [46]
    GTCR Completes Investment in JMG Group
    Led since 2020 by a partnership of CEO Nick Houghton and Chairman Tim Johnson, JMG has rapidly scaled into a top 30 UK broker, placing over £350 ...
  47. [47]
    How This Chicago Private Equity Firm Scored The Biggest Exit Of ...
    Jul 2, 2025 · The Chicago-based firm's $45 billion in assets under management pale in comparison to Wall Street's biggest players like Blackstone, Apollo and ...
  48. [48]
    FTC challenges $627M private equity takeover of Surmodics
    Mar 7, 2025 · The Federal Trade Commission has challenged a private equity firm's attempt to buy Surmodics for approximately $627 million, the regulator said ...
  49. [49]
    FTC Challenges Medical Device Coatings Deal
    Mar 6, 2025 · The FTC charges that private equity firm GTCR's proposed acquisition of Surmodics would create a combined company controlling more than 50% of the market for ...
  50. [50]
    Surmodics Issues Statement on U.S. Federal Trade Commission ...
    Mar 6, 2025 · The FTC is challenging Surmodics' acquisition by GTCR, which Surmodics disagrees with and intends to defend in court. The merger was approved ...
  51. [51]
    April 17, 2025 Press Release - Minnesota Attorney General
    Apr 17, 2025 · The FTC first sued to block GTCR's acquisition of Surmodics on March 6, 2025; today, Attorney General Ellison and Illinois Attorney General ...
  52. [52]
    Ex-Rauner partner details nursing home investment struggles
    Sep 26, 2014 · A former partner in Bruce Rauner's GTCR equity firm testified Friday at a Tampa bankruptcy trial that the company's investment in a controversial nursing home ...
  53. [53]
    Nursing Home Neglect Trial Challenges Shell Company Transfers
    Sep 22, 2014 · “The GTCR Funds had no interest in having companies in which they had invested millions of dollars sell off subsidiaries for less than they were ...
  54. [54]
    Nursing Home Liabilities Transfer Could Be Fraud: Judge
    Dec 17, 2014 · GTCR lost more than $60 million on its investment in Trans Healthcare, he said. “It was a financial disaster” for GTCR, he said. The ...
  55. [55]
    Private Equity Health Care Acquisitions – March 2021
    Apr 20, 2021 · GTCR is a prolific health care investor, with at least 11 current health care portfolio companies and almost 50 past investments.[ii] Multiple ...<|separator|>
  56. [56]
    GTCR Completes Acquisition of FMG, the Leading Marketing ...
    Sep 10, 2025 · PRNewswire/ -- GTCR, a leading private equity firm, announced today that it has closed the previously announced acquisition of FMG Suite ...
  57. [57]
    GTCR Buys MarTech Platform FMG From Private Equity Owner
    Jul 29, 2025 · GTCR, the private equity firm backing AssetMark and Captrust, will help FMG build out its product suite and expand its AI capabilities.
  58. [58]
    GTCR Acquires Innovative Systems - PR Newswire
    Aug 27, 2025 · CHICAGO, Aug. 27, 2025 /PRNewswire/ -- GTCR, a leading private equity firm, announced today that it has acquired Innovative Systems (the " ...
  59. [59]
    Innovative Systems acquired by investment firm - Payments Dive
    The South Dakota billing and payments software company was purchased by the Chicago private equity firm GTCR. Published Aug. 28, 2025.
  60. [60]
    GTCR Acquires Innovative Systems - Markets Group
    Aug 27, 2025 · GTCR has acquired Innovative Systems, a leading broadband software platform, partnering with CEO Scott Alcott to drive growth and expansion.
  61. [61]
    https://www.gtcr.com/gtcr-completes-acquisition-of-adts-commercial-fire-and-security-segment/
  62. [62]
    GTCR Completes Acquisition of ADT's Commercial Fire and Security ...
    GTCR, a leading private equity firm, announced today that it has closed the acquisition of ADT's commercial security, fire and life safety security business.
  63. [63]
    GTCR Completes Acquisition of ADT's Commercial Fire and Security ...
    Oct 2, 2023 · GTCR, a leading private equity firm, announced today that it has closed the acquisition of ADT's commercial security, fire and life safety security business.
  64. [64]
    SimpliSafe Signs Definitive Agreement to be Acquired by GTCR
    Sep 15, 2025 · SimpliSafe marks GTCR's fifth investment in the security alarm industry, including prior investments in residential-focused security companies ...
  65. [65]
    GTCR's McConnell Details Big, Quick Worldpay Exit - Bloomberg
    May 2, 2025 · Global Payments agreed to acquire Worldpay from Fidelity National Information Services and private equity firm GTCR for $24.3 billion.<|separator|>
  66. [66]
    GTCR to return over $5bn to LPs in 2024 following string of high ...
    The wave of distributions is being driven by a series of successful exits, including a two-times return from the $24.25bn carve-out of Worldpay. The landmark ...
  67. [67]
    GTCR | Institution Profile - Private Equity International
    Founded in 1980, GTCR is a private equity firm that focuses on investing in growth companies in the consumer, fintech, healthcare, technology, ...
  68. [68]
    Constantine S. Mihas - GTCR
    Dean joined GTCR in 2001 and is currently a Co-CEO and Managing Director of the firm. Prior to joining GTCR, Dean was CEO and co-founder of Delray Farms, LLC.<|separator|>
  69. [69]
    Collin E. Roche - GTCR
    Collin joined GTCR in 1996 and is currently a Co-CEO and Managing Director of the firm. Previously, Collin was an Associate at EVEREN Securities in Chicago.
  70. [70]
    GTCR Announces Promotions and New Team Appointments Across ...
    Oct 13, 2025 · Founded in 1980, GTCR is a leading private equity firm that invests behind The Leaders Strategy™ – finding and partnering with management ...
  71. [71]
    M&A News: Global M&A Deals Week of September 8 to 14, 2025
    Sep 16, 2025 · Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports | Reuters · GTCR to acquire generic drug maker Zentiva. Deal No. 4 ...Top 5 M&a Deals For The Week · Deal No. 1 · Deal No. 2<|separator|>
  72. [72]
    How GTCR got a 2x return in 2 years with Worldpay - PitchBook
    Aug 12, 2025 · A small handful of deals spiked M&A deal value in Q2. One payment processor, backed by GTCR, was at the heart of the momentum. August 12, 2025.
  73. [73]
    Bruce Rauner, 'business guy' or politician? - Chicago Tribune
    Oct 18, 2014 · GTCR grew to manage $11 billion in investments, much of it for public worker pension funds, while tapping those resources to buy and sell ...
  74. [74]
    GTCR and Bruce Rauner in spotlight again with ... - Chicago Tribune
    Jun 16, 2013 · GTCR deals have involved layoffs, heavy debts, a regulatory investigation and an involuntary bankruptcy. Rauner is “proud of his role in ...
  75. [75]
    GTCR's The Leaders Strategy paves the way for successful ...
    Jun 17, 2022 · GTCR pioneered The Leaders Strategy, which involves partnering with management leaders in core domains to identify, acquire and build market-leading companies.Missing: philosophy | Show results with:philosophy
  76. [76]
    https://www.gtcr.com/leadership-stories/
  77. [77]
    Leadership Case Study Stories - GTCR Private Equity
    Cole-Parmer: Building a Leader in Life Sciences and Lab Products through The Leaders Strategy™. Healthcare · Cord Blood Registry: Investing in Life Sciences.
  78. [78]
    GTCR investors set to reap over $5 billion as exits pile, source says
    May 22, 2025 · GTCR's sale of Worldpay last month netted the firm a return two times its investment, the source added, with the $24.25 billion three-way deal ...Missing: IRR performance
  79. [79]
    GTCR Races to $5 Billion Return Record After Flurry of Sales
    May 22, 2025 · GTCR is on track to return a record $5 billion-plus to investors for a calendar year, thanks to its active dealmaking in 2025 and recent exits.<|control11|><|separator|>
  80. [80]
    GTCR sets target for newly launched capital solutions business
    Jun 27, 2024 · Recent performance data ; GTCR Fund XIII (2020 vintage): Net IRR: 17.70%; Net TVPI: 1.25x; Net DPI: 0.21x ; GTCR Fund XII (2017 vintage): Net IRR: ...
  81. [81]
    GTCR in five charts - Private Equity International
    Oct 18, 2017 · GTCR in five charts. Following the close of the Chicago-based firm's largest-ever fund on $5.25bn, Private Equity International takes a look at ...<|separator|>
  82. [82]
    In a sluggish dealmaking environment, mid-sized buyout pioneer ...
    Jul 4, 2025 · The fund GTCR used to buy Sterigenics had returns of 13.77 percent as of the end of June, according to one investor, the Illinois State Board of ...
  83. [83]
    Announces Agreement for GTCR to Acquire Majority Stake in ... - FIS
    Jul 6, 2023 · FIS to retain 45% ownership in Worldpay. GTCR committed to invest up to $1.25 billion in additional growth capital to accelerate Worldpay growth strategy.
  84. [84]
    GTCR Forms Portfolio Resources Group to Support Portfolio ...
    Aug 17, 2022 · GTCR is focused on investing in transformative growth in companies in the Business & Consumer Services, Financial Services & Technology, ...Missing: efficiency | Show results with:efficiency
  85. [85]
    GTCR - Stephens Inc.
    Aug 27, 2025 · ... Leaders StrategyTM – finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies ...
  86. [86]
    GTCR trial full of political peril for Rauner - Chicago Tribune
    Sep 28, 2014 · The trial boils down to this: The estates of six late residents in Trans Healthcare-connected nursing homes in Florida secured wrongful death awards.Missing: disputes | Show results with:disputes
  87. [87]
    Judge issues ruling in $1 billion nursing home case, says IL ...
    Trans Healthcare Inc. — was facing 150 lawsuits. Judgments eventually totaled more than $2 billion.
  88. [88]
    Nursing Home Neglect Trial Challenges Shell Company Transfers
    Sep 23, 2014 · ... wrongful death lawsuits or collecting judgments, said lawyers for the family of Jackson, who was 76 when she died. Trans Healthcare Inc. and ...
  89. [89]
    Nursing Home Neglect Trial Fights Shell Company Transfers
    Sep 22, 2014 · ... wrongful death lawsuits or collecting judgments, said lawyers for the family of Jackson, who was 76 when she died. Trans Healthcare Inc. and ...
  90. [90]
    GTCR trial full of political peril for Rauner – Orlando Sentinel
    Jannotta testified that he and GTCR had no motive to evade liability for wrongful death lawsuits against the chain because the business was insured for such ...
  91. [91]
    Rauner Avoids Responsibility in Nursing Home Tragedies
    Sep 14, 2020 · A jury agreed with her family, deciding that Trans Healthcare should pay $110 million for her wrongful death. Trans Healthcare and Trans ...
  92. [92]
    Client Alert: FTC Challenges Medical Device Coating Transaction
    Mar 12, 2025 · The FTC alleges that the transaction violates the Clayton Act because GTCR holds a majority stake in another leading provider of hydrophilic ...
  93. [93]
    FTC's First Merger Challenge Under New Leadership Signals ...
    Mar 12, 2025 · On March 6, 2025, the Federal Trade Commission (FTC) filed a lawsuit in federal court challenging GTCR BC Holdings, LLC's (GTCR) proposed ...
  94. [94]
    GTCR / Surmodics: Four Key Takeaways for M&A Antitrust from the ...
    Mar 11, 2025 · The FTC challenged the GTCR/Surmodics merger, using 2023 guidelines, focusing on healthcare, and may seek "prior approval" for future deals. ...<|separator|>
  95. [95]
    GTCR, Surmodics, US FTC disagree on facts, the law in court ... - MLex
    Sep 25, 2025 · The FTC filed a lawsuit in March to prevent GTCR from acquiring Surmodics, and the parties recently concluded a two-week hearing to determine ...
  96. [96]
    US FTC delays GTCR BC Holdings-Surmodics' evidentiary hearing ...
    Sep 30, 2025 · The US Federal Trade Commission granted GTCR BC Holdings and Surmodics' motion to continue its evidentiary hearing until Feb. 2, 2026.
  97. [97]
    A Return to Traditional M&A? Insights from First Merger Challenge of ...
    Sep 29, 2025 · [1] “Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of ...Missing: opposition | Show results with:opposition
  98. [98]
    New Report Exposes the Destructive Impact of Private Equity on ...
    Feb 14, 2025 · “Private equity firms have turned tax loopholes into a weapon—siphoning profits from businesses, workers, and communities while their executives ...
  99. [99]
    [PDF] The (Heterogenous) Economic Effects of Private Equity Buyouts
    Gross job destruction in the wake of divisional targets exceeds that of controls by 10% of base employment, mostly due to jobs lost in facility closures.
  100. [100]
    Private Equity and Employment | NBER
    Private equity buyouts accelerate job losses at target firms relative to controls, they also lead to the more rapid creation of new job positions.
  101. [101]
    Private equity holds the key to creating quality jobs for millions
    Jan 10, 2024 · Private equity firms generate vast economic output – nearly 12 million jobs in the United States and 6.5% of the country's gross domestic ...Missing: GTCR | Show results with:GTCR
  102. [102]
    Private Equity: In Essence, Plunder? - CFA Institute Blogs
    Aug 2, 2024 · Statistically, there is an increased risk of failure with private equity ownership. PE portfolio companies are about 10 times as likely to go bankrupt as non- ...
  103. [103]
    Leveraged Buyouts and Private Equity
    While the empirical evidence is consistent overall with significant operating improvements for leverage buyouts, it should be interpreted with some caution.
  104. [104]
    Private-Equity Buyouts: Job Killers or Productivity Boosters?
    Dec 10, 2013 · Private-equity groups are often portrayed by critics as corporate raiders who destroy jobs. But research out of Chicago Booth finds that ...